Vanguard Group Inc Cytokinetics Inc Call Options Transaction History
Vanguard Group Inc
- $5.46 Trillion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CYTK
# of Institutions
404Shares Held
124MCall Options Held
4.6MPut Options Held
2.43M-
Black Rock Inc. New York, NY14.7MShares$714 Million0.02% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD9.69MShares$471 Million0.31% of portfolio
-
Wellington Management Group LLP Boston, MA7.77MShares$378 Million0.07% of portfolio
-
State Street Corp Boston, MA6.46MShares$314 Million0.01% of portfolio
-
Bank Of America Corp Charlotte, NC4.83MShares$235 Million0.02% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $4.58B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...